Small Caps
The Surge of RxSight and Other Stocks Shaking Up the Market
RxSight, Inc.RXST soared during Monday’s session after the company released preliminary FY23 and FY24 revenue guidance that topped estimates. Additionally, Needham upped its price ...
Insights into Ardelyx Stock Movement
Insights into Ardelyx Stock Movement
Ardelyx, Inc. ARDX shares are trading higher Monday after the company provided a strategic business update. Here’s a look at what’s going on. The ...
Should You Invest in Spectaire Holdings, Dorian LPG, Ginkgo Bioworks, Dada Nexus, or Ampio Pharmaceuticals?
Thinking about investing in these stocks? Read this first!
NEW YORK, Jan. 8, 2024 /PRNewswire/ — InvestorsObserver issues critical PriceWatch Alerts for SPEC, LPG, DNA, DADA, and AMPE. To see how InvestorsObserver’s proprietary ...
Monday Stock Focus: Commercial Metals, Boot Barn, and More
Monday Stock Focus: Commercial Metals, Boot Barn, and More
With U.S. stock futures trading lower this morning on Monday, some of the stocks that may grab investor focus today are as follows: Key ...
Investor Pressure Mounts for External BP CEO Candidates
Investor Pressure Mounts for External BP CEO Candidates
Push for External Candidate With a history stretching back 114 years, BP has long been characterized by its tradition of internal CEO appointments. However, ...
Analyst Bullish On Phathom Pharmaceuticals
Expert Analyst Sees Bright Future for Phathom Pharmaceuticals With Voquezna Launch
Needham analyst Joseph Stringer reiterated a Buy rating on Phathom Pharmaceuticals, Inc.PHAT, raising the price target to $26 from $23. “PHAT is our top ...
Bearish Report Predicts Chegg’s Demise
Bearish Report Predicts Chegg’s Demise
Chegg, Inc. CHGG shares have plummeted nearly 60% over the past year, and a recently released report by Edwin Dorsey’s “The Bear Cave” is ...
Cannabis Revolutionizes Cancer Management, Confirms New Research
Cannabis Revolutionizes Cancer Management, Confirms New Research
A groundbreaking study recently published in the Journal of Cancer Survivorship has unveiled the widespread adoption of cannabis among individuals who have triumphed over ...
Allogene Therapeutics Shakes up Strategy: Bold Move, Says Expert
Allogene Therapeutics Shakes up Strategy: Bold Move, Says Expert
Allogene Therapeutics Inc ALLO has announced a significant strategic shift, deprioritizing the currently enrolling third-line Phase 2 ALPHA2 and EXPAND trials of cema-cel (ALLO-501A) in ...
Greenbrier’s Shares Surge on Q1 FY24 Results
Greenbrier’s Shares Surge on Q1 FY24 Results
Greenbrier Companies Inc GBX shares are trading higher by around 8% on Friday after the company reported Q1 FY24 results. Q1 FY24 Results Overview Greenbrier’s Q1 ...
